Product Code: RP-ID-10352121 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10352121
Market Overview:
Global Neuroprosthetics Market Analysis & Outlook 2030
In 2021, the global neuroprosthetics market is estimated at USD 12 billion. Serious diseases such as Parkinsons disease, epilepsy, hearing, ophthalmology, neuromuscular/muscular disease, Alzheimers disease and severe depression are the main causes of the development of this disease. In addition, R&D investment is expected to increase for the development of effective treatment programs for neuropathy, the development of BCI (Brain Interface Computer) devices, and the discovery of new devices and products with innovative technologies for self-reliance. Growth - The demand for brain transplants is expected to increase due to the burden of bioenergy transplants during the forecast period. The demand for neural implants will increase during the forecast period. ..
Technical Perspective:
Spinal cord stimulators (SCS) gained the largest market share in the technology sector, exceeding 50% in 2020. This advantage is due to the greater impact associated with the introduction of high-tech devices, along with advanced applications in the field of motor impairment, sensory. Functionality and independence: Adoption of commercial technologies such as Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS). ) is used across technology market segments and is expected to grow significantly. The introduction of technologically advanced devices such as local field functions (LFP), mobile robots and sensors, magnetic resonance imaging and surgical implants are expected to provide future growth opportunities for this market. Sacred Nerve Stimulator (SNS) is the fastest growing technology on the market to improve therapeutic interventions in therapies aimed at alleviating neurological dysfunction.
Knowledge Type:
Mobility prosthetics had the largest market share in 2020, followed by spiral prosthetics. The Kinetic Prosthesis segment held the largest market share due to the growing use of bladder-controlled implants and brain interfaces for patients with spinal cord injury and lateral sclerosis. B. Used for deaf use such as ABI and AMI brainstem transplantation. Cochlear implants are used for signal processing and stimulation therapy, paving the way for future treatment of neurological disorders.
Practical Conclusion:
Neurosurgery is widely used to treat a variety of neurological disorders, such as Alzheimers disease, Parkinsons disease, spinal cord injury, and trauma. According to the application, artificial nervous system can be divided into movement disorders, physiological disorders and cognitive disorders. In 2015, as Parkinsons disease and epilepsy became common, the prevalence of these diseases increased, and the number of users of motor neuron diseases increased, the popularity of artificial nervous systems increased. On the other hand, cognitive impairment is expected to increase rapidly due to the increase in the prevalence of Alzheimers disease and major depression. The introduction of advanced implants, which can enumerate long-term routes used to treat paralysis, is expected to drive further market growth during the forecast period.
Regional Outlook:
North America recorded the highest sales in 2020, accounting for 45% of the overall market share. Many of these have been imposed by factors such as public and private households and existing health care facilities. In the European market, neural implants are expected to grow rapidly due to increasing government initiatives to develop advanced devices for deaf people. Emerging markets have untapped opportunities. The goal is to reduce the overall cost of implant manufacturing and educate patients about the industry growth drivers for this sector. In addition, investment from industry players is expected to increase over the next few years in the form of new manufacturing facilities with high growth potential for neuroimplants.
Competitive Market Overview:
Cochlear Ltd., Cyberonics Inc. and Medtronic Inc. and NDI Medical LLC and Neurorace, Inc. They are the major players in the prosthetic market. Companies such as Boston Scientific Corporation and St. provide efficient and technologically advanced solutions such as wireless microphones, smart hearing aids, stimulators, and advanced neurotherapy systems. Strategic cooperation and geographic growth are part of the sustainable strategy of these actors, which should keep the industry competitive at a high level during the forecast period and drive the growth of the overall market.
Related Reports
Proof of Quality & Reliability
